blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2114940

EP2114940 - AZA-ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - 613 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.03.2012
Database last updated on 15.06.2024
Most recent event   Tooltip02.03.2012Application deemed to be withdrawnpublished on 04.04.2012  [2012/14]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2009/46]
Inventor(s)01 / SLASSI, Abdelmalik
4780 Fulwell Road
Mississauga, Ontario L5M 7J7 / CA
02 / ISAAC, Methvin
17 Reynolds Ave.
Brampton, Ontario L6P 2C1 / CA
03 / CLAYTON, Joshua
1321 Ashwood Terrace
Oakville, Ontario L6M 4A7 / CA
04 / EGLE, Ian
1700 Eglinton Ave. E.Ste 318 North York
Ontario M4A 2X4 / CA
05 / JOSEPH, Babu
1112 Goodson Cres
Oakville, Ontario L6H 4A5 / CA
06 / MA, Fupeng
1 Oak Grove Ave. Unit 315
Melrose, MA 02176 / US
 [2009/47]
Former [2009/46]01 / SLASSI, Abdelmalik
4780 Fulwell Road
Mississauga, Ontario L5M 7J7 / CA
02 / ISAAC, Methvin
17 Reynolds Ave.
Brampton, Ontario L6P 2C1 / CA
03 / CLAYTON, Joshua
1156 Pilgrims Way
Oakville, Ontario L6M 1H1 / CA
04 / EGLE, Ian
36 Webster Way
Georgetown, Ontario L7G 5J7 / CA
05 / JOSEPH, Babu
1112 Goodson Cres
Oakville, Ontario L6H 4A5 / CA
06 / MA, Fupeng
1 Oak Grove Ave. Unit 315
Melrose, MA 02176 / US
Application number, filing date08728676.131.01.2008
[2009/46]
WO2008US52609
Priority number, dateUS20070900318P09.02.2007         Original published format: US 900318 P
[2009/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008100715
Date:21.08.2008
Language:EN
[2008/34]
Type: A1 Application with search report 
No.:EP2114940
Date:11.11.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 21.08.2008 takes the place of the publication of the European patent application.
[2009/46]
Search report(s)International search report - published on:EP21.08.2008
ClassificationIPC:C07D471/04, A61K31/437, A61P25/00
[2009/46]
CPC:
C07D471/04 (EP,US); A61P1/08 (EP); A61P13/02 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P27/02 (EP); A61P27/16 (EP); A61P29/02 (EP);
A61P31/18 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/46]
TitleGerman:AZA-ISOINDOLONE UND IHRE VERWENDUNG ALS METABOTROPE GLUTAMAT-REZEPTOR-POTENTIATOREN - 613[2009/46]
English:AZA-ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - 613[2009/46]
French:AZA-ISO-INDOLONES ET LEUR UTILISATION COMME POTENTIATEURS DU RÉCEPTEUR DU GLUTAMATE MÉTABOTROPE - 613[2009/46]
Entry into regional phase09.09.2009National basic fee paid 
09.09.2009Designation fee(s) paid 
09.09.2009Examination fee paid 
Examination procedure09.09.2009Examination requested  [2009/46]
22.12.2009Despatch of a communication from the examining division (Time limit: M06)
30.06.2010Reply to a communication from the examining division
06.05.2011Communication of intention to grant the patent
17.09.2011Application deemed to be withdrawn, date of legal effect  [2012/14]
25.10.2011Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2012/14]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.12.2009
Fees paidRenewal fee
01.02.2010Renewal fee patent year 03
31.01.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9842666  (DAE WOONG PHARMA [KR], et al) [X] 1,8,9 * the whole document *;
 [X]  - Y YAMAMOTO ET AL., "Synthesis of 2-haloalkylpyridines via Cp*RuCl-catalyzed cycloaddition of 1,6-diynes with alpha-halonitriles", ADV. SYNTH. CATAL., (2005), vol. 347, pages 1913 - 1916, XP002483083 [X] 1-3 * compound 6a, 6e, 6j *

DOI:   http://dx.doi.org/10.1002/adsc.200505193
 [X]  - G DEGUEST ET AL., "One-pot synthesis og 2,3-dihydro-pyrolopyridinones using in situr generated formimines", ORG. LETT., (2006), vol. 8, no. 25, pages 5889 - 5892, XP002483084 [X] 1-3 * compounds 4a, 18 *

DOI:   http://dx.doi.org/10.1021/ol062577c
 [X]  - Y YAMAMOTO ET AL., "Ruthenium-catalyzed cycloaddition of 1,6-diynes and nitriles udner mild conditions", CHEM. EUR. J., (2006), vol. 12, pages 5618 - 5631, XP002483085 [X] 1-3 * compounds 24a, 24h, 24k *

DOI:   http://dx.doi.org/10.1002/chem.200600176
 [X]  - PARCHINSKY V Z ET AL, "Practical outcome of azaphthalimide reduction with Zn/AcOH at various temperatures", LETTERS IN ORGANIC CHEMISTRY, BENTHAM SCIENCE PUBLISHERS LTD., HILVERSUM, NL, (20060101), vol. 3, no. 5, ISSN 1570-1786, pages 379 - 383, XP008092364 [X] 1-3 * compound 6a *

DOI:   http://dx.doi.org/10.2174/157017806776611890
 [X]  - RA NADZHAFOVA, "Reaction of ethyl 6-alkyl(aryl)-4-chloromethyl-2-methyl-pyridine-3-carboxylates with ammonia and primary amines", RUSS. J. ORG. CHEM., (2002), vol. 38, no. 1, pages 126 - 128, XP002483086 [X] 1,2,4 * compounds IIIb,c; IVb,c; Vb,c *
 [A]  - TASLER S ET AL, "Non-competitive inhibitors of metabotropic glutamate receptor 5 (mGluR5)", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20050602), vol. 15, no. 11, ISSN 0960-894X, pages 2876 - 2880, XP004906914 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2005.03.089
by applicant   - SCHOEPP ET AL., TRENDS PHARMACOL. SCI., (1993), vol. 14, no. 13
    - SCHOEPP, NEUROCHEM. INT., (1994), vol. 24, page 439
    - PIN ET AL., NEUROPHARMACOLOGY, (1995), vol. 34, page 1
    - BORDI; UGOLINI, PROG. NEUROBIOL, vol. 59, (1999), page 55, URL: Prog. Neurobiol
    - PIN ET AL., EUR. J. PHARMACOL., (1999), vol. 375, pages 277 - 294
    - BASHIR ET AL., NATURE, (1993), vol. 363, page 347
    - BORTOLOTTO ET AL., NATURE, (1994), vol. 368, page 740
    - AIBA ET AL., CELL, (1994), vol. 79, page 365
    - ARAMORI ET AL., NEURON, (1992), vol. 8, page 757
    - TANABE ET AL., NEURON, (1992), vol. 8, page 169
    - MILLER ET AL., J. NEUROSCIENCE, (1995), vol. 15, page 6103
    - BALAZS ET AL., J. NEUROCHEMISTRY, (1997), vol. 69, page 151
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.